
Research Post Doc Fellow – Neonatology – Children’s Hospital of Philadelphia – Philadelphia, PA
Candidates who have a background in lung research, animal models of human lung disease, in vitro models to study lung… Click here to view original post
Candidates who have a background in lung research, animal models of human lung disease, in vitro models to study lung… Click here to view original post
A Bachelor’s degree in Biology, Microbiology, or other related scientific discipline and a minimum of 1 year of relevant experience… Click here to view original post
The hospital would mark the Allentown-based health system’s latest push into the Philadelphia region. Click here to view original post
The *Pharmaceutical Sales Rep* is a key member of the team and plays a critical role in supporting our customer… Click here to view original post
The new vision and rehabilitation center at UPMC Mercy is one step closer to opening with the completion of a key construction milestone. Click here to view original post
Two National Leading Providers in Revenue Cycle Staffing Solutions Joining Forces PLYMOUTH MEETING, Pa., June 30, 2022 /PRNewswire/ — GHR Healthcare (“GHR”), the parent company of seven strategic staffing brands spanning healthcare, wellness, travel nursing, […]
Earlier this year, Novartis touted its radioligand as a major piece to counter competition in the cancer space. However, the physical production of its products has had anything but a smooth ride. In May, Novartis […]
North American headquarters project is global company’s second expansion under Wolf Administration Harrisburg, PA – Governor Tom Wolf announced today that Almac Group, a global contract pharmaceutical development and manufacturing organization, is expanding its North […]
The rise of pharma environmental, social and governance (ESG) efforts in the past two years has been meteoric as investors turn their attention to sustainable funding. However, investors aren’t the only ones watching. Patients are […]
Microbiome pioneer Seres Therapeutics faced numerous setbacks throughout the years in numerous fields, most prominently for its lead program in C. difficile infections. But the biotech has plotted a comeback after a major flop six […]
Copyright © 2022 Biotech Networks, LLC